by Truveta Staff | Jul 19, 2022 | News
Don’t forget to add our upcoming webinar to your calendar: Advancing Clinical Research Through Unprecedented Data and a Learning Community for Health. On July 26th at 1:00 PM ET | 10:00 AM PT, Terry Myerson, Truveta’s CEO, and Ryan Ahern, MD, MPH. Truveta’s Chief...
by Truveta Staff | Jun 21, 2022 | News
Real World Data on a grand scale empowers Pfizer to identify, monitor, and evaluate potential signals immediately using complete Electronic Medical Record data, updated daily for more than 50 million people. Truveta today announced a strategic collaboration with...
by Truveta Research | Jun 21, 2022 | Research, Research Insights
Long COVID is a term used to describe patients with returning or sustained symptoms following a SARS-CoV-2 infection. Physicians and researchers have described numerous post COVID-19 complications, including cardiovascular, coagulation and hematologic,...
by Truveta Research | May 23, 2022 | Research, Research Insights
The COVID-19 pandemic affected every aspect of many of our lives. For some, it affected how we work, where we work, who we interact with, and the frequency at which we interact with others. As we thought about the various impacts of social distancing, we were curious...
by Truveta Research | Mar 8, 2022 | Research, Research Insights
After looking at the Truveta COVID-19 dashboard, our Research Team was curious about the breakthrough rates for specific disease types and how they compared between fully vaccinated individuals with and without booster shots. The team took the data in the dashboard...
